English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Since last few years plasma cell dyscrasias have been in the hit list of research especially pertaining to its therapy and pathophysiology. India has taken a great leap as far as research in plasma cell dyscrasias is concerned. The year started with myeloma conference in New Delhi conducted by Army Hospital (R&amp;R) and ended at Haematocon Kochi organised by team from CMC Vellore (Haematocon 2018). Haematocon 2018 provided an exceptional platform for the research on various aspects of plasma cell dyscrasias both from the country and abroad. A total of 23 abstracts were presented pertaining to plasma cell disorders; 13 original research papers, 08 case reports and 02 case series. There were a wide spectrum of papers which ranged from the discussion about morphological aspects, mimickers, clinical spectrum, life style in the setting of the disease, diagnostic modalities to management aspects and finally to progress and survival of these patients. Through this review we will summarize and analyze the key findings of the original research abstracts on diagnosis, risk stratification, clinical profile and treatment aspects of plasma cell disorders presented at the Haematocon 2018.

Highlights of Abstracts on Plasma Cell Dyscrasia in the Annual Conference ISHBT (Kochi)